Claudia Marchetti

@ESGO_society @enygo @EngageEsgo @OncoAlert Only 238 days to #ESGO2025 in Rome !!!

Italian #meetings mean food and good weather!🌈 @GSK @annafagottimd @clamarchetti81

@leitaomd @IJGConline @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @agz_eriksson @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @annafagottimd @ijgc Someone said, not long ago, that any case-control study can be “nested” within the interior of a cohort study… so we’re all right! 😉

@IJGConline @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @agz_eriksson @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @annafagottimd Sorry @IJGC but this is not a true case-control study as is in the title! It is a mere retrospective cohort analysis.

Trabectedin+pegylated liposomal doxorubicin in patients w/ disease progression after #PARPi maintenance 🔗 bit.ly/3KuLbUc @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @agz_eriksson @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @annafagottimd

Amazing and super fruitful discussions during the Mayo Clinic - Gemelli meeting held at Policlinico Gemelli in Rome 🤩 proud to be part of this group! @annafagottimd @pedroramirezMD @frafanfani @ESGO_society @ENYGO_official @IGCSociety @clamarchetti81 @FMultinu @IJGCfellows

Welcome to #ESGO2021 to all my fantastic colleagues from Italy 🇨🇮 Great Gemelli team !!!